MENU
LOGIN
SUBSCRIBE
Nov
7
Singapore's Hummingbird mulls Hong Kong IPO
just now
Cailian Press
Hummingbird Bioscience, a Singapore-based biotech firm, is said to be considering an IPO in Hong Kong next year, according to people familiar with the matter.
Share
Latest Pulses
See All
Most Recent
Insights
East Asia to see biggest growth for US IPOs next year, says Nasdaq
Features
Coolfly’s “uneconomical” sprint for one user shows the kind of company it aims to be
News
Kling AI launches Video 2.6 with native audio generation to speed end-to-end content creation
See All